日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Bireociclib Plus Fulvestrant in Advanced Breast Cancer After Endocrine Progression: The BRIGHT-2 Phase 3 Randomized Clinical Trial

比瑞西尼联合氟维司群治疗内分泌进展后的晚期乳腺癌：BRIGHT-2 III期随机临床试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2026.0318
Wang, Jiayu; Zhang, Qingyuan; Li, Huiping; Tong, Zhongsheng; Ouyang, Quchang; Li, Huihui; Teng, Yuee; Wang, Biyun; Sun, Tao; Wang, Jingfen; Li, Wei; Niu, Zhaofeng; Li, Hongsheng; Gong, Chang; Wang, Shu; Wang, Xinshuai; Wu, Xinhong; Liu, Ning; Yu, Guohua; Hu, Yan; Wang, Qiuli; Duan, Xianghui; Yang, Fan; Wang, Li; Xu, Binghe
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

A Cu(II)-Based Fluorescent Probe for Carbon Monoxide, Nap-BC-Cu(II), Does Not Selectively Detect Carbon Monoxide

一种基于Cu(II)的荧光探针Nap-BC-Cu(II)用于检测一氧化碳，但它不能选择性地检测一氧化碳。

期刊:Molecules
影响因子:4.6
doi:10.3390/molecules31030415
Liu, Dongning; Li, Hongliang; Challa, Shivanagababu; Wang, Binghe
IF
发表日期：2026
文献求助 收藏

Efficacy of neoadjuvant endocrine therapy with CDK4/6 inhibitors in locally advanced breast cancer

CDK4/6抑制剂新辅助内分泌治疗在局部晚期乳腺癌中的疗效

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyag032
Zhang, Mengqi; Li, Mingxiao; Zhou, Shihan; Jiang, Mingxia; Liu, Jiaxuan; Yang, Xue; Qin, Ling; Abudureheiyimu, Nilupai; Shi, Xiuqing; Li, Lixi; Li, Fengjuan; Guan, Xiuwen; Ma, Fei; Xu, Binghe; Li, Qiao
CDK4
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study

PARP抑制剂治疗携带同源重组修复通路基因突变的转移性乳腺癌患者的疗效和安全性：一项回顾性多中心真实世界研究

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359251411096
Peng, Xuenan; Song, Ruixia; Fan, Ying; Wang, Jiayu; Li, Qiao; Mo, Hongnan; Wang, Jiani; Luo, Yang; Chen, Shanshan; Sun, Xiaoying; Zhang, Jintao; Zhang, Pin; Xu, Binghe; Lan, Bo; Ma, Fei
肿瘤
肿瘤免疫
信号转导
乳腺癌
PARP
发表日期：2026
文献求助 收藏

Factors influencing corneal edema after phacoemulsification combined with intraocular lens implantation in elderly diabetic cataract patients and establishment of a predictive model

影响老年糖尿病性白内障患者行超声乳化联合人工晶体植入术后角膜水肿的因素及预测模型的建立

期刊:Medicine
影响因子:1.4
doi:10.1097/MD.0000000000048046
Ainiwaer, Maierdanjiang; Hong, Yingying; Xiao, Binghe; Ning, Li; Ji, Yinghong
糖尿病
白内障
代谢
发表日期：2026
文献求助 收藏

Comparison of 2.2 mm vs. 2.6 mm corneal incisions in phacoemulsification in hard nuclear cataracts: impact on intraoperative energy and postoperative corneal recovery

比较2.2 mm与2.6 mm角膜切口在硬核性白内障超声乳化术中的应用：对术中能量和术后角膜恢复的影响

期刊:Frontiers in Ophthalmology
影响因子:0.9
doi:10.3389/fopht.2026.1732396
Ainiwaer, Maierdanjiang; Hong, Yingying; Xiao, Binghe; Ning, Li; Ji, Yinghong
白内障
发表日期：2026
文献求助 收藏

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01

达托泊单抗德鲁替康对比化疗治疗既往接受过治疗的不可手术/转移性激素受体阳性、人表皮生长因子受体2阴性乳腺癌：TROPION-Breast01研究的主要结果

期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00920
Bardia, Aditya; Jhaveri, Komal; Im, Seock-Ah; Pernas, Sonia; De Laurentiis, Michelino; Wang, Shusen; Martínez Jañez, Noelia; Borges, Giuliano; Cescon, David W; Hattori, Masaya; Lu, Yen-Shen; Hamilton, Erika; Zhang, Qingyuan; Tsurutani, Junji; Kalinsky, Kevin; Rubini Liedke, Pedro Emanuel; Xu, Lu; Fairhurst, Rick M; Khan, Sabrina; Denduluri, Neelima; Rugo, Hope S; Xu, Binghe; Pistilli, Barbara
肿瘤
肿瘤免疫
信号转导
乳腺癌
Human
免疫/内分泌
发表日期：2025
文献求助 收藏

Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial

瑞博西尼联合内分泌治疗激素受体阳性/ERBB2阴性早期乳腺癌：NATALEE随机临床试验的4年结果

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2025.3700
Fasching, Peter A; Stroyakovskiy, Daniil; Yardley, Denise A; Huang, Chiun-Sheng; Crown, John; Bardia, Aditya; Chia, Stephen; Im, Seock-Ah; Martin, Miguel; Xu, Binghe; Loi, Sherene; Barrios, Carlos; Untch, Michael; Moroose, Rebecca; Visco, Frances; Hortobagyi, Gabriel N; Slamon, Dennis J; Fresco, Rodrigo; Zarate, Juan Pablo; Li, Zheng; Waters, Sorcha; Hurvitz, Sara A
肿瘤
肿瘤免疫
ERBB2
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Tactile-Transparent Wearable Sensor for Clinician-Friendly Pulse Wave Velocity Monitoring and Cardiovascular Risk Profiling

用于临床医生友好型脉搏波速度监测和心血管风险评估的触觉透明可穿戴传感器

期刊:ACS Nano
影响因子:16
doi:10.1021/acsnano.5c11375
Hou, Senlin; Chen, Xiaotong; Assi, Dani S; Feng, Yu; Wong, Chun-Ka; Tian, Jingting; Li, Jian; Yu, Xiaodong; Guan, Binghe; Zhu, Xiaohu; Yu, Xinge; Li, Xinyue; Roy, Vellaisamy A L; Shen, Jiangang; Li, Wen Jung
发表日期：2025
文献求助 收藏

Lerociclib plus fulvestrant in patients with HR+/HER2- locally advanced or metastatic breast cancer who have progressed on prior endocrine therapy: LEONARDA-1 a phase III randomized trial

在既往接受过内分泌治疗后病情进展的HR+/HER2-局部晚期或转移性乳腺癌患者中，Lerociclib联合氟维司群的疗效：LEONARDA-1 III期随机试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-025-56096-2
Xu, Binghe; Zhang, Qingyuan; Luo, Yang; Tong, Zhongsheng; Sun, Tao; Shan, Changping; Liu, Xinlan; Yao, Yumin; Zhao, Bing; Wang, Shusen; Zeng, Xiaohua; Hu, Changlu; Yan, Xi; Wang, Xiaojia; Jia, Hongyan; Chen, Zhendong; Qiu, Fuming; Wu, Xinhong; Zhang, Deyong; Li, Tong
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏